BioNTech
WEBWir führen Sie durch die spannende Welt der Immuntherapien. Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten.
BioNTech stärkt Produktionsstandort Marburg durch erste ...
WEBFeb 2, 2023 · BioNTech stellt mit unternehmenseigener Plasmid-Herstellungsstätte die Produktion von zentralem Ausgangsmaterial für ihre Onkologie- und COVID-19-Impfstoffpipeline unabhängiger und flexibler auf; Die Investition in Höhe von rund 40 Millionen Euro ist Teil eines langfristigen Entwicklungsplans für den Standort Marburg
All BioNTech locations at a glance
WEBFrom Mainz out into the world. Discover BioNTech's global network and find all contact information for our locations.
Inside BioNTech's Factory Where Pfizer Vaccine Is Made | TIME
WEBApr 19, 2021 · BioNTech currently produces 8 million doses of its vaccine every three to seven days at the new Marburg facility that the company purchased from Novartis last fall.
BioNTech | Modern manufacturing processes for the production …
WEBLarge parts of the production take place in-house at our principal manufacturing facility in Marburg. Additionally, we trust in our strong partnerships with companies that contribute their expertise to various steps of the production process.
BioNTech provides Update on Vaccine Production Status at Marburg …
WEBMar 26, 2021 · The approvals make BioNTech’s Marburg manufacturing site one of the largest mRNA vaccine manufacturing sites in Europe as well as worldwide with an annual production capacity of up to one billion doses of our …
‘Where the magic happens’ — inside BioNTech’s innovative …
WEBApr 2, 2021 · Marburg facility in Germany is first to make approved coronavirus vaccine using mRNA technology. The Marburg facility is set to produce about a quarter of the 2.5bn doses Pfizer and BioNTech...
BioNTech starts vaccine production at new site in Germany
WEBFeb 10, 2021 · Vaccine developer BioNTech has launched production of the COVID-19 vaccine it developed with US giant Pfizer at a new plant in the German town of Marburg. The facility could significantly boost...
BioNTech Strengthens Manufacturing Capabilities with First
WEBFeb 2, 2023 · BioNTech's site in Marburg is one of the largest manufacturing facilities for mRNA-based vaccines in Europe. As part of its long-term development plan, BioNTech has continuously invested...
Update on vaccine production at BioNTech’s manufacturing site in Marburg
WEBMAINZ, GERMANY, February 10, 2021 (GLOBE NEWSWIRE) - We started the manufacturing process at the Marburg facility with the execution of the first step: the production of mRNA, which is the active...